Jan 25 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2022 Dec 31, 2021 Mar 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 3.73 3.47 5.10
(+7.5 pct) (+9.2 pct) (+10.5 pct)
Operating 699 mln 662 mln 900 mln
(+5.7 pct) (+27.5 pct) (+20.4 pct)
Recurring 722 mln 671 mln 900 mln
(+7.6 pct) (+26.8 pct) (+15.7 pct)
Net 497 mln 457 mln 600 mln
(+8.7 pct) (+34.1 pct) (+17.1 pct)
EPS 119.24 yen 112.65 yen 143.75 yen
Ann Div 25.00 yen 25.00 yen
-Q2 div NIL NIL
-Q4 div 25.00 yen 25.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T